MedTrace Logo

Nanochon Chondrograft First in Human (FIH) Early Feasibility Study (EFS) - Canada

NCT07249489 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-04-22

No results posted yet for this study

Summary

The goal of this First in Human study is to learn if the Nanochon Chondrograft Implant is a safe primary surgical treatment for participants with cartilage lesions in the knee. This study will include males and females between the ages of 22 and 60.

Conditions

  • Knee Cartilage Lesions

Interventions

DEVICE

Nanochon Chondrograft

Mini arthrotomy or arthroscopic surgical implantation of the Nanochon Chondrograft

Sponsors & Collaborators

  • Nanochon, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2027-08-31
Completion
2027-08-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07249489 on ClinicalTrials.gov